(taken from application) The classic major histocompatibility complex (MHC) class I and class II pathways are well established in antigen presentation. In addition, the CD1 family of proteins are now recognized to likely represent another class of molecules that are important in unique aspects of antigen processing and activation of distinct subsets of T-cells such as those contained within the gut and liver. Human CD1 consists of 5 genes (CD1AE) that are encoded on chromosome 1 outside the MHC locus. Human CDI has strong structural similarities to MHC class I but also shows several features in common with MHC class II, suggesting a distinct relationship to both of the previously characterized classical MHC molecules. CDld, a member of this family, is prominently displayed on intestinal epithelial cells (IEC) and hepatocytes. Furthermore, the expression of CDld is increased in immune-mediated gastrointestinal diseases, such as inflammatory bowel disease and celiac disease. Although the exact role of CDld in the mucosal immune system is unclear, CD1 d exhibits unique biochemical properties and functional characteristics. CDld is expressed on the cell surface of normal IECs as a 37-kD, nonglycosylated molecule independently of pi2-microglobulin which is clearly distinct from all other MHC class I-related molecules. In addition, this biochemical form of CD1d is directly involved in the proliferation of T-cells to normal IECs. In order to understand the function of this unique antigen-presenting molecule in human intestine and liver, it will be important to: (1) identify interacting proteins which are involved in biosynthesis and/or assembly of CDld using the yeast two-hybrid system, phage display technologies, and biosynthetic labelling; (2) characterize the responses of human intestinal lymphocytes to CDld by measuring proliferation and cytokine production, and (3) identify CDld interacting surface ligand(s) on T-cells using immunoprecipitation with Fc-CDld fusion protein.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08DK002549-01
Application #
2451829
Study Section
Special Emphasis Panel (SRC)
Program Officer
Podskalny, Judith M,
Project Start
1998-07-01
Project End
1999-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Arrunategui-Correa, Victor; Lenz, Laurel; Kim, Hyun Sil (2004) CD1d-independent regulation of NKT cell migration and cytokine production upon Listeria monocytogenes infection. Cell Immunol 232:38-48
Arrunategui-Correa, Victor; Kim, Hyun Sil (2004) The role of CD1d in the immune response against Listeria infection. Cell Immunol 227:109-20
Maaser, Christian; Eckmann, Lars; Paesold, Gunther et al. (2002) Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology 122:667-80
Kim, H S; Colgan, S P; Pitman, R et al. (2000) Human CD1d associates with prolyl-4-hydroxylase during its biosynthesis. Mol Immunol 37:861-8
Kim, H S; Garcia, J; Exley, M et al. (1999) Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J Biol Chem 274:9289-95